Menu
Not yet recruiting NCT07659873

Advancing Online Psychology Tools for Chronic Pain

No phase Interventional Fibromyalgia Chronic Pelvic Pain Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Digital psychology intervention (ADOPT-CP), Reminder Emails.
Who it may be relevant to
Registry conditions: Fibromyalgia, Chronic Pelvic Pain Syndrome. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Advancing Online Psychology Tools for Chronic Pain (ADOPT-CP): Feasibility of a Scalable Digital Psychology Intervention and AI-Powered Support for Patients on the Waitlist for Pain Services

Overview

Chronic pain affects more than 20% of Canadians and is associated with significant impacts on physical function, mental health, and quality of life. Despite efforts to improve access to multidisciplinary pain care through centralized referral systems, many patients continue to experience prolonged wait times before receiving treatment. This study evaluates a self-guided digital psychological intervention designed to support chronic pain self-management during the waiting period for specialized pain care. The intervention was developed through a collaboration between the Transitional Pain Service and ManagingLife and aims to improve access to evidence-based psychological support, enhance self-management skills, and reduce pain-related distress among individuals living with chronic pain.

Detailed description

The Advancing Online Psychology Tools for Chronic Pain (ADOPT-CP) intervention provides participants with access to the Manage My Pain (MMP) platform, including a self-guided Acceptance and Commitment Therapy (ACT)-based digital psychology program and Solace, an artificial intelligence (AI)-enabled conversational support tool for chronic pain. Together, these tools are designed to support pain self-management, emotional coping, and engagement in care.

This study will evaluate the feasibility, acceptability, and preliminary clinical effects of the ADOPT-CP intervention among individuals waiting to access multidisciplinary chronic pain services through the Toronto Academic Pain Medicine Institute (TAPMI). The intervention aims to provide accessible psychological support and self-management resources during the waiting period for specialized pain care.

Interventions

  • Other Digital psychology intervention (ADOPT-CP)
    The intervention, Manage My Pain (MMP), is a clinically validated app-based platform that supports individuals with chronic pain in self-managing their symptoms and improving communication and engagement with their care team.
  • Other Reminder Emails
    Weekly emailed pain self-management resources introduced during the Toronto Academic Pain Medicine Institute (TAPMI) orientation

Primary outcome measures

  • Trial feasibility [Time frame: 10 weeks]
  • Engagement with the digital ADOPT-CP intervention [Time frame: 10 weeks]
  • Acceptability and Appropriateness of the ADOPT-CP intervention [Time frame: 10 weeks]
  • Acceptability and Adherence of the ADOPT-CP intervention [Time frame: 10 weeks]
  • Experience using the ADOPT-CP intervention [Time frame: 14 weeks]
Secondary outcome measures (5)
  • Quality of Life and Pain Interference [Time frame: 10 weeks]
  • Pain Acceptance [Time frame: 10 weeks]
  • Psychological Flexibility [Time frame: 10 weeks]
  • Kinesiophobia [Time frame: 10 weeks]
  • Pain Resiliency [Time frame: 10 weeks]

Eligibility criteria

Inclusion criteria

  • Must be deemed to have capacity to provide informed consent;
  • Must sign and date the informed consent form;
  • Must state willingness to comply with all study procedures;
  • Must be at least 18 years of age;
  • Must be referred to TAPMI;
  • Must have either fibromyalgia or chronic pelvic pain
  • Must be on the waitlist at TAPMI;
  • Must have access to a device that can connect to the Internet with access to email.

Exclusion criteria

  • Currently engaged in psychotherapy or engaged in psychotherapy within the last month at the time of enrolment;
  • Unable to read, understand, or communicate in English sufficiently to provide informed consent and complete the study procedures and questionnaires;
  • Has active serious mental illness or psychiatric instability that, in the opinion of the research team, may impair the ability to safely participate in the study or to provide informed consent (e.g., active psychosis, active mania);
  • Has a visual, auditory, or other functional impairment that would prevent independent access to and use of the digital intervention and study procedures on an internet-enabled device.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Canada · 1 center
  • Women's College Hospital — Toronto

Identifiers

NCT: NCT07659873 · 2026-

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗